“PERSONALIZED THERAPY IN CARDIOLOGY: THE ROLE OF PHARMACOGENETICS AND BIOMARKERS IN THE SELECTION OF ANTIHYPERTENSIVE AND ANTIPLATELET AGENTS - POTENTIAL AND LIMITATIONS OF IMPLEMENTATION”, Genetics and Mol. Res., May 2026, doi: 10.4238/z3e7ft80.